CRL 41835
Alternative Names: CRL 41833Latest Information Update: 27 Oct 2011
At a glance
- Originator Cephalon France
- Class Antiplatelets; Small molecules
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 26 Mar 2007 Discontinued - Preclinical for Thrombosis in France (unspecified route)
- 23 Sep 1998 No-Development-Reported for Thrombosis in France (Unknown route)
- 29 Aug 1996 Preclinical development for Thrombosis in France (Unknown route)